Mr Mfazo Hove Featured in Newsweek: GLP-1 Medications and Vision Loss Posted Medically Reviewed by: Mr Mfazo Hove, Consultant Ophthalmic Surgeon Author: Chris Dunnington Published: July 16, 2026 Last Updated: July 16, 2026 Mr Mfazo Hove, Consultant Ophthalmic Surgeon and Medical Director of Blue Fin Vision, has been invited by Newsweek to comment on new international research linking GLP-1 medications to a rare optic nerve condition that can cause sudden vision loss
S., Novak, M., and Monkus, E
KLOW blend (KPV, GHK-Cu, BPC-157, TB-500): a four-peptide formulation that further adds KPV, studied for its anti-inflammatory profile, alongside the GLOW components
Biotin, in particular, supports the production of keratin, a protein that makes up hair, skin, and nails